CLX

Business Context and Reporting Period

Company: The Clorox Company (CLX)
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Three months ended September 30, 2024 (Fiscal Q1 2025)
Business Overview: A leading multinational manufacturer of consumer and professional products operating in Health and Wellness, Household, Lifestyle, and International segments. The period was characterized by a recovery from the August 2023 cyberattack and the strategic divestiture of the Better Health Vitamins, Minerals, and Supplements (VMS) business.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Net sales increased 27% year-over-year, driven primarily by a 31% organic sales growth. This surge is largely attributed to lapping the negative impacts of the August 2023 cyberattack which disrupted operations in the prior year.
• Profitability: Gross margin expanded by 740 basis points to 45.8%, fueled by higher volume and cost savings. Diluted EPS increased 371% to $0.80.
• Divestiture Impact: The company recorded a one-time after-tax loss of $118 million related to the divestiture of the Better Health VMS business on September 10, 2024. Proceeds from the sale were $128 million.
• Cyberattack Recovery: The company recognized $10 million in insurance recoveries in Q1 2024, compared to $24 million in incremental costs incurred in Q1 2023. Operations have returned to normalized levels.
• Segment Performance:
  • Health and Wellness: Sales up 38%; Adjusted EBIT up 126%.
  • Household: Sales up 38%; Adjusted EBIT improved from a loss of $4 million to $60 million.
  • Lifestyle: Sales up 40%; Adjusted EBIT up 247%.
  • International: Sales down 4% due to the Argentina divestiture, though Adjusted EBIT remained stable.

Guidance, Outlook, and Risks

Management Commentary: Management anticipates a volatile and challenging operating environment for Fiscal 2025 due to elevated interest rates, geopolitical instability, and consumer spending pressure. However, the company expects to continue generating annual cost savings from its streamlined operating model and digital transformation initiatives.

Capital Allocation:

• Share Repurchases: Purchased 789,000 shares for $107 million during the quarter. Approximately $993 million remains available under the open-market program.
• Dividends: Declared a quarterly dividend of $2.44 per share.

Risks and Contingencies:

• Macroeconomic Factors: Risks include supply chain disruptions, raw material cost volatility, and geopolitical conflicts (Middle East, Ukraine, China-Taiwan).
• Cybersecurity: Ongoing risks related to IT system reliance and potential future breaches.
• Environmental: Recorded liabilities of $28 million for environmental remediation, with potential for additional costs if regulators require expanded actions.
• Digital Transformation: Implementation of a new ERP system may impact internal controls and incur incremental costs over the next five years.

Investor Verification Checklist

• Divestiture Accounting: Verify the $118 million loss on the VMS divestiture and confirm the $128 million net proceeds received.
• Cyberattack Normalization: Assess the sustainability of the 27% sales growth by comparing current volumes to pre-cyberattack levels (FY2023) rather than just the disrupted FY2024 Q1.
• Non-GAAP Reconciliations: Review the reconciliation of Adjusted EBIT ($332M) to GAAP Earnings Before Tax ($177M) to understand the impact of the divestiture loss, cyberattack costs, and digital investment expenses.
• Debt Covenants: Confirm compliance with the Credit Agreement's minimum 4.0x Interest Coverage ratio, especially given the one-time loss impact on GAAP earnings.
• Environmental Liabilities: Monitor the status of the Alameda County and Dickinson County remediation matters, as final costs could exceed the current $28 million accrual.